MENU
TRML
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tourmaline Bio (TRML) Ownership - Who owns Tourmaline Bio?
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases... Show more
Profile
Industry
N/A
Address
27 West 24th Street
Phone
+1 646 481-9832
Employees
44
Web
https://www.tourmalinebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
329.54M
P/E Ratio
N/A
Total Cash
258.3M
Projected Growth
N/A
Total Debt
244K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
10.06
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TRML
Capitalization
330M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
258M
Total Cash/Share
10.06
Total Debt
244K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
300M
P/B Ratio
1.10
Cash Flow
N/A
Earnings
-2.89
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
30.18
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-89.69M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.20
Shares Held By Institutions
543M
Shares Outstanding - Current
25.7M
Total Liabilities
8.95M
Total Volume MTD
N/A
Value
1
Gain YTD
-35.306
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
27 West 24th Street
Phone
+1 646 481-9832
Employees
44
Web
https://www.tourmalinebio.com